Navigation Links
Significantly higher success rates with artificial insemination
Date:2/6/2008

This release is also available in German.

In future a new method could help some couples who are childless against their will. The microscopic procedure significantly improves the success rate of 'ICSI' (intracytoplasmic sperm injection). This was discovered by scientists at the University of Bonn together with colleagues from China and industrial partners in a study of 124 women. Up to now, the desire to have a child is only fulfilled for every third couple that decides to have ICSI. In a study the artificial insemination method was twice as successful. The scientists have now published their data in the journal 'Reproductive BioMedicine'. (Online version available at http://www.rbmonline.com/Article/3161).

For many couples ICSI is the last resort in their attempt to have a child. 'The method is recommended if the man produces too few sperm cells,' the Bonn reproductive biologist Dr. Markus Montag explains. Doctors can in most cases still extract individual functioning sperm cells from testicular tissue, which they then inject into the ovum. The partner must take hormone preparations before an ICSI. They result in several ova maturing in the ovaries, normally it is only one ovum per month.

'We inject a sperm into every one of these cells,' Markus Montag explains. 'Then it takes more than 26 hours until the plasmosomes of the ovum and sperm cell fuse and an embryo forms. In this time frame we have to decide which of the fertilised ova to insert into the uterus. The reason for this is that the German law for the protection of embryos lays down that only a maximum of three fertilised ova are allowed to be implanted per attempt. 'We even restrict ourselves to only two, in order to exclude the possibility of births of triplets,' Markus Montag explains. With pregnancies involving multiple births there is an increased risk of miscarriages and malformations.

Choosing the 'best' ova

Which of the fertilised ova are finally implanted has usually been left up to chance. But today it is known that not all ova have the same quality. Using a special procedure the Bonn scientists can select the two most suitable candidates. 'For this we observe the ovule integument under a DIC microscope,' Dr. Montag explains. 'There it appears as a luminescent orange-red ring. The brighter this ring is and the more uniformly it shines, the greater the chance that it becomes a child.' The reason for this is that the ovule integument always seems to have a particularly uniform structure if the cell has matured under good conditions.

Normally every third ICSI is successful. But if medics used two 'good ' ova in their experiment, this rate increased to more than 50 per cent. With a 'good' and a 'bad' ovum the success rate was still around 40 per cent, using two 'bad' ones only 20 per cent. 'Mind you, two good ova are rare,' Markus Montag emphasises. 'Only with two out of ten cells does the ovule integument have an intense regular orange colour.'

Under natural conditions insemination takes place in the oviduct. After that the ovum begins to divide, while contractions of the oviduct transport it to the uterus. This process takes just under 2-3 days. When the embryo lodges in the endometrium on the sixth day after insemination, the embryo consists of several hundred cells. During the whole process the embryo is protected by the ovule integument.

The Bonn team led by Dr. Markus Montag and Professor Hans van der Ven has developed software in conjunction with the Octax Microscience Company, which analyses the image from the microscope objectively and proposes the most suitable cells. 'This way the procedure can be implemented in clinical routine without problems and without much effort,' he says.


'/>"/>

Contact: Markus Montag
Markus.Montag@ukb.uni-bonn.de
49-022-828-715-449
University of Bonn
Source:Eurekalert

Related medicine news :

1. New findings show Enbrel significantly reduced levels of C-reactive protein
2. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
3. Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
4. Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers
5. Tonsillectomy significantly improves quality of life in adult and pediatric patients
6. Adult ADHD significantly impacts on social, financial and personal aspects of life
7. Transports Phase 2 Data Show Single Treatment SoloVir(TM) ETS Significantly Stops Progression of Cold Sore Episode
8. PET imaging significantly enhances standard imaging in lung cancer staging
9. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
10. Ranexa(R) Significantly Reduces Ischemia in Women in MERLIN TIMI-36 Study
11. Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery ... Arizona pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic ... , Dr. Olson says the decision to support the pageant in an ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based ... however, are unsure how to move forward, given the need to sustain current ... forward tailored to an organization’s specific needs. , PYA Principal Martie Ross states, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: